Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC ARCC-4 | 1973403-00-7 | 99.9% | 1024.18 g·mol⁻1 | C53H56F3N7O7S2 | 5 MG
Supplier: Medchemexpress LLC HY1304925MG
ARCC-4 is a PROTAC-based androgen receptor degrader intended for biochemical and cellular research. The molecule is enzalutamide-derived and recruits the von Hippel-Lindau E3 ligase to induce androgen receptor degradation at low nanomolar potency (reported DC50 ≈ 5 nM). Supplied as a dry powder with storage instructions for long-term stability.
- Potent androgen receptor degrader with low-nanomolar activity.
- Enzalutamide-derived VHL-recruiting PROTAC mechanism.
- Active against clinically relevant androgen receptor mutants.
- Provided as a dry powder suitable for biochemical and cellular assays.
- Long-term storage stability: powder -20°C for 3 years, 4°C for 2 years.
- High chemical purity for reproducible experimental results.
- Available in small mass packages for research use.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?